Palleiko Benjamin L bought KALV
September 6, 2025 · Form 4 insider transaction
Palleiko Benjamin L bought 15,625 shares of KalVista Pharmaceuticals Inc, a transaction worth N/A. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 3 days after the transaction.
Direction
Acquired (buy-side)
Shares
15,625
Price
N/A
Total value
N/A
InsiderPalleiko Benjamin L
RoleOfficer, Director
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateSeptember 6, 2025
Filing dateSeptember 9, 2025
Shares owned after402,483
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Each restricted stock unit ("RSU") represents a contingent right to receive 1 share of the Issuer's Common Stock upon settlement for no consideration.